And this guy thinks he needs negative news for his stock to tank, maybe he never understood the meaning of bagholder LOL! Today he's thinking some terror plot was the cause, not realizing the real forces at work are beyond his comprehension. PCYC setting up for lower prices.
Well, from the looks of it, there are better stocks to be short in than PCYC or the biotechs in general. Mortimer_duke was, I believe, holding a big position in THRX ahead of today's FDA approval, so he will probably not be too stung by your condescension.
This was take from Earnings Preview: J&J 1Q to focus on newest drugs. This week, the FDA granted a third breakthrough therapy designation for a cancer drug still in testing, ibrutinib. That’s meant to speed up late-phase testing and review of the drug. J&J plans this year to seek approval for the drug as a treatment for mantle cell lymphoma.
Thats within 8 months folks..